Abstract
Rosmarinus officinalis L. (Lamiaceae), popularly known as rosemary, is used for food flavoring, and in folk medicine, as an antispasmodic, analgesic, anti-rheumatic, diuretic, and antiepileptic agent. Rosemary is an herb widely used in folk medicine, cosmetics, and phytotherapy and for flavoring of food products. Studies have focused on various biological activities of the secondary metabolites of this plant, such as rosmarinic acid, which have powerful antioxidant, hepato-protective, antimicrobial, anti-nociceptive, and anti-inflammatory properties.
Keywords: Anti-oxidant, cytokines, phytotherapy, Rosmarinus officinalis, rosmarinic acid, anti-inflammatory agent.
Reviews on Recent Clinical Trials
Title:Rosmarinic Acid as Potential Anti-Inflammatory Agent
Volume: 13 Issue: 4
Author(s): Carmela Colica, Laura Di Renzo, Vincenzo Aiello, Antonino De Lorenzo and Ludovico Abenavoli*
Affiliation:
- Department of Health Sciences, University "Magna Graecia" of Catanzaro, Campus "Salvatore Venuta", 88100 Germaneto, Catanzaro,Italy
Keywords: Anti-oxidant, cytokines, phytotherapy, Rosmarinus officinalis, rosmarinic acid, anti-inflammatory agent.
Abstract: Rosmarinus officinalis L. (Lamiaceae), popularly known as rosemary, is used for food flavoring, and in folk medicine, as an antispasmodic, analgesic, anti-rheumatic, diuretic, and antiepileptic agent. Rosemary is an herb widely used in folk medicine, cosmetics, and phytotherapy and for flavoring of food products. Studies have focused on various biological activities of the secondary metabolites of this plant, such as rosmarinic acid, which have powerful antioxidant, hepato-protective, antimicrobial, anti-nociceptive, and anti-inflammatory properties.
Export Options
About this article
Cite this article as:
Colica Carmela , Di Renzo Laura , Aiello Vincenzo , De Lorenzo Antonino and Abenavoli Ludovico *, Rosmarinic Acid as Potential Anti-Inflammatory Agent, Reviews on Recent Clinical Trials 2018; 13 (4) . https://dx.doi.org/10.2174/157488711304180911095818
DOI https://dx.doi.org/10.2174/157488711304180911095818 |
Print ISSN 1574-8871 |
Publisher Name Bentham Science Publisher |
Online ISSN 1876-1038 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pleiotropic Effects of Fenofibrate
Current Pharmaceutical Design Ligands and Therapeutic Perspectives of Adenosine A2A Receptors
Current Pharmaceutical Design The Antidiabetic Potential of Quercetin: Underlying Mechanisms
Current Medicinal Chemistry Detection of Protein-Protein Interactions Using Protein-Fragment Complementation Assays (PCA)
Current Proteomics Dapsone Hypersensitivity Syndrome (DHS): A Detrimental Effect of Dapsone? A Case Report
Current Drug Safety Flaxseed can Prevent Adverse Effects of Toluene on Human Ovarian Cell Functions
Current Bioactive Compounds Editorial (Hot Topic: Palmitoylethanolamide: Biochemistry, Pharmacology and Therapeutic Use of a Pleiotropic Anti-Inflammatory Lipid Mediator)
CNS & Neurological Disorders - Drug Targets Angiogenesis and Angiogenic Inhibitors in Non Small Cell Lung Cancer
Current Angiogenesis (Discontinued) Cystic Fibrosis, Vector-Mediated Gene Therapy, and Relevance of Toll-Like Receptors: A Review of Problems, Progress, and Possibilities
Current Gene Therapy Drug Repurposing for Retinoblastoma: Recent Advances
Current Topics in Medicinal Chemistry Development and Anti-microbial Potential of Topical Formulations Containing Cocos nucifera Linn.
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Current Therapeutic Approaches in Inflammatory Bowel Disease
Current Pharmaceutical Design Oxidative Stress and the JNK Pathway in Diabetes
Current Diabetes Reviews RANKL/RANK/OPG: Key Therapeutic Target in Bone Oncology
Current Drug Discovery Technologies Pattern Recognition by CD6: A Scavenger-Like Lymphocyte Receptor
Current Drug Targets Immunomodulatory Drugs (IMiDs) in Multiple Myeloma
Current Cancer Drug Targets Treatment of Clopidogrel Hypersensitivity: The Jefferson Approach
Current Vascular Pharmacology Treasures Hunt in Old Mines: Terminalia chebula-Based Traditional Herbal Medicinal Products
The Natural Products Journal Tumor Necrosis Factor-α, a Regulator and Therapeutic Agent on Breast Cancer
Current Pharmaceutical Biotechnology An Emerging Role of Endometrial Inflammasome in Reproduction: New Therapeutic Approaches
Protein & Peptide Letters